Cover Image
市場調查報告書

連網型注射藥物輸送設備市場預測:傳統設備·自我注射型設備·其他

Connected Injectable Drug Delivery Devices Market: By Type (Conventional, Self-Injection, Others); By Connected Technology (Wireless, Bluetooth, Apps, NFC); By Disease (Anaphylaxis, Cardiovascular, Diabetes, etc); By Geography - (2015-2022)

出版商 IndustryARC 商品編碼 622669
出版日期 內容資訊 英文 163 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
連網型注射藥物輸送設備市場預測:傳統設備·自我注射型設備·其他 Connected Injectable Drug Delivery Devices Market: By Type (Conventional, Self-Injection, Others); By Connected Technology (Wireless, Bluetooth, Apps, NFC); By Disease (Anaphylaxis, Cardiovascular, Diabetes, etc); By Geography - (2015-2022)
出版日期: 2017年09月27日 內容資訊: 英文 163 Pages
簡介

本報告提供全球連網型注射藥物輸送設備的市場調查,提供市場定義和概要,競爭環境與市場佔有率,市場的各種影響因素及市場機會分析,價值鏈,產品生命週期分析,設備類型·技術·用途·終端用戶·地區/各主要國家趨勢與市場規模的變化與預測,並彙整主要企業簡介等資訊。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 競爭經營者分析
    • 產品基準
    • 終端用戶的簡介
    • 前五名公司的財務分析
    • 專利分析

第4章 市場影響因素

  • 成長推進因素
  • 阻礙成長要素·課題
  • 波特的五力分析

第5章 策略性市場分析

  • 價值鏈分析
  • 價格分析
  • 市場機會分析
  • 產品·市場生命週期

第6章 市場分析·預測:不同設備類型

  • 簡介
  • 吸入器
  • 注射器
    • 手持設備
    • 穿戴式設備
  • 固態劑型
  • 其他

第7章 市場分析·預測:各技術

  • 簡介
  • Bluetooth
  • 智慧型手機應用程式
  • NFC
  • 緊急技術

第8章 市場分析·預測:各用途

  • 簡介
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 荷爾蒙補充
  • 神經科
  • 呼吸系統疾病
  • 其他

第9章 市場分析·預測:各終端用戶

  • 簡介
  • 醫院
  • 診療所
  • 居家照護

第10章 市場分析·預測:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲&紐西蘭
    • 其他
  • 其他地區
    • 南美
    • 中東
    • 非洲

第11章 市場熵

  • 擴張
  • 技術開發
  • M&A·JV
  • 供給契約

第12章 企業簡介

  • Phillips-Medisize Corporation
  • West Pharmaceutical Services, Inc.
  • Biocorp
  • Aterica, Inc.
  • Unilife Corporation
  • Panasonic
  • Propeller Health
  • Qualcomm Technologies, Inc.
  • Haselmeier
  • SHL Group

第13章 附錄

目錄

Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition. These drug delivery devices helps in addressing the patient consistence issues with the medication treatment, disease management protocols which are major concerns for healthcare professionals and pharmaceutical industry. Before bringing a connected health offering to life, it is important to understand the fundamentals of patient-centric design. One of the most successful elements in fulfilling the need for patient-centric design is human factors analysis, which benefits the patient by making injection systems more comfortable and user-friendly.

Connected injectable drug delivery devices market is comprehended by device type, technology, application and end user. By device type the market is further segmented into inhalation devices, injection devices, solid dosage forms and others. Whereas injection devices are further sub segmented into handheld devices and wearable devices. Based on technology the market is categorized into Bluetooth, smart phone apps, near field communication (NFC) and emergency technologies. By application the market is further segmented into diabetes, cardiovascular diseases, autoimmune diseases, hormones replacement, neurology, addiction, respiratory diseases and others. Based on end users the market is categorized into hospitals, clinics and homecare settings.

Connected injectable drug delivery devices market is further analyzed on the basis of regions such as: North America, Europe, Asia-Pacific and Row.

Sample Companies profiled in this report are:

Phillips-Medisize Corporation (U.S.),

West Pharmaceutical Services, Inc. (U.S.),

Biocorp (France),

Aterica, Inc. (Canada),

Unilife Corporation (U.S.),

10+.

Growing prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer coupled with increasing compliance to the treatment owing to use of these devices. Increased interest of pharmaceutical or medical devices companies to surge consumer compatibility and application is expected to propel the growth of the market in the near future.

The research methodology opted for this report incorporates initial segregation of the market by device type, technology, application, end user and region. This was followed by mining of market volume and revenue of different device type of connected injectable drug delivery devices employed by various applications with respect to regions is considered. Bottom up approach was then followed for estimating the global market size and its forecast for period 2017 to 2023. The data figures and supporting insights so collated were validated through primary research process by Key Opinion Leaders (KOLs) which comprised of manufacturers, distributors, suppliers, associations and end users.

1. Connected Injectable Drug Delivery Devices Market - Overview

2. Connected Injectable Drug Delivery Devices Market - Executive Summary

3. Connected Injectable Drug Delivery Devices - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End User Profiling
    • 3.2.3. Top 5 Financials Analysis
    • 3.2.4. Patent Analysis

4. Connected Injectable Drug Delivery Devices Market - Forces

  • 4.1. Drivers
  • 4.2. Constraints & Challenges
  • 4.3. Portera€™s Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Degree of Competition

5. Connected Injectable Drug Delivery Devices Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life cycle Analysis

6. Connected Injectable Drug Delivery Devices Market - By Device Type

  • 6.1. Introduction
  • 6.2. Inhalation devices
  • 6.3. Injection Devices
    • 6.3.1. Handheld Devices
    • 6.3.2. Wearable Devices
  • 6.4. Solid Dosage Forms
  • 6.5. Others

7. Connected Injectable Drug Delivery Devices Market - By Technology

  • 7.1. Introduction
  • 7.2. Bluetooth
  • 7.3. Smart Phone Apps
  • 7.4. Near Field Communication
  • 7.5. Emergency Technologies

8. Connected Injectable Drug Delivery Devices Market - By Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Cardiovascular Diseases
  • 8.4. Autoimmune Diseases
  • 8.5. Hormones Replacement
  • 8.6. Neurology
  • 8.7. Addiction
  • 8.8. Respiratory Diseases
  • 8.9. Others

9. Connected Injectable Drug Delivery Devices Market - By End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Clinics
  • 9.4. Homecare Settings

10. Connected Injectable Drug Delivery Devices Market - By Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. Europe
    • 10.3.1. U.K.
    • 10.3.2. Germany
    • 10.3.3. France
    • 10.3.4. Italy
    • 10.3.5. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia-Pacific
  • 10.5. Row
    • 10.5.1. South America
    • 10.5.2. Middle East
    • 10.5.3. Africa

11. Connected Injectable Drug Delivery Devices - Market Entropy

  • 11.1. Expansion
  • 11.2. Technological Developments
  • 11.3. Merger & Acquisitions, and Joint Ventures
  • 11.4. Supply- Contract

12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 12.1. Phillips-Medisize Corporation
  • 12.2. West Pharmaceutical Services, Inc.
  • 12.3. Biocorp
  • 12.4. Aterica, Inc.
  • 12.5. Unilife Corporation
  • 12.6. Panasonic Corporation
  • 12.7. Propeller Health
  • 12.8. Qualcomm Technologies, Inc.
  • 12.9. Haselmeier
  • 12.10. SHL Group

More than 10 Companies are profiled in this Research Report*

"*Financials would be provided on a best efforts basis for private companies"

13. Appendix

  • 13.1. Abbreviations
  • 13.2. Sources
  • 13.3. Research Methodology
  • 13.4. Bibliography
  • 13.5. Compilation of Expert Insights
  • 13.6. Disclaimer
Back to Top